BioSpace News Archive

Echosens, a high-technology company offering the FibroScan family of products, joins the American Liver Foundation, in observance of Liver Cancer Awareness Month, urging increased awareness of non-alcoholic fatty liver disease (NAFLD) and its more severe form called non-alcoholic steatohepatitis (NASH), which is projected to become the leading cause for liver transplants by the year 2020.

A new Barcode Assessment study conducted by AmerisourceBergen Corporation, McKesson Pharmaceutical and Cardinal Health, in collaboration with GS1 US®, revealed that 74.3% of pharmaceutical barcodes scanned in the wholesalers’ facilities meet the 2013 Drug Supply Chain Security Act (DSCSA) serialization requirements—

Zebra Medical Vision, the deep learning medical imaging analytics company, announced a partnership with Emergent Connect, a leading provider of cloud-based PACS software.

More than 860 teams participated in the competition with the goal of developing machine learning methods that identify representations of biology from Recursion’s first-ever open-source dataset

Auris Health, Inc. (“Auris Health”), part of Johnson & Johnson Medical Devices Companies,* today announced results from a study demonstrating the safety and feasibility of the Monarch Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures

COPAN continues to innovate and is leading the field of Artificial Intelligence (A.I.) and digital culture plate reading in clinical Microbiology.

Award is one of the highest honors in the category of field service, recognizing commitment to outstanding innovation, leadership and excellence

MediciNova, Inc. announced that it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-001 for the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Boston Scientific Corporation generated sales of $2.707 billion during the third quarter of 2019.

Alexion Pharmaceuticals, Inc. announced financial results for the third quarter of 2019.